Alto Neuroscience
Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform. Learn more
Launch date
Employees
Market cap
€334m
Enterprise valuation
€167m (Public information from Sep 2024)
Share price
$13.43 ANRO
Los Altos California (HQ)
Authorizing premium user...